158 related articles for article (PubMed ID: 15757392)
1. Agents and strategies in development for improved management of herpes simplex virus infection and disease.
Kleymann G
Expert Opin Investig Drugs; 2005 Feb; 14(2):135-61. PubMed ID: 15757392
[TBL] [Abstract][Full Text] [Related]
2. Novel agents and strategies to treat herpes simplex virus infections.
Kleymann G
Expert Opin Investig Drugs; 2003 Feb; 12(2):165-83. PubMed ID: 12556212
[TBL] [Abstract][Full Text] [Related]
3. New antiviral drugs that target herpesvirus helicase primase enzymes.
Kleymann G
Herpes; 2003 Aug; 10(2):46-52. PubMed ID: 14577954
[TBL] [Abstract][Full Text] [Related]
4. The management of herpes simplex virus infections.
Yeung-Yue KA; Brentjens MH; Lee PC; Tyring SK
Curr Opin Infect Dis; 2002 Apr; 15(2):115-22. PubMed ID: 11964910
[TBL] [Abstract][Full Text] [Related]
5. New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease.
Kleymann G; Fischer R; Betz UA; Hendrix M; Bender W; Schneider U; Handke G; Eckenberg P; Hewlett G; Pevzner V; Baumeister J; Weber O; Henninger K; Keldenich J; Jensen A; Kolb J; Bach U; Popp A; Mäben J; Frappa I; Haebich D; Lockhoff O; Rübsamen-Waigmann H
Nat Med; 2002 Apr; 8(4):392-8. PubMed ID: 11927946
[TBL] [Abstract][Full Text] [Related]
6. Penciclovir cream--improved topical treatment for herpes simplex infections.
Schmid-Wendtner MH; Korting HC
Skin Pharmacol Physiol; 2004; 17(5):214-8. PubMed ID: 15452407
[TBL] [Abstract][Full Text] [Related]
7. Antiviral agents for herpes simplex virus.
Vere Hodge RA; Field HJ
Adv Pharmacol; 2013; 67():1-38. PubMed ID: 23885997
[TBL] [Abstract][Full Text] [Related]
8. Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance.
James SH; Prichard MN
Curr Opin Virol; 2014 Oct; 8():54-61. PubMed ID: 25036916
[TBL] [Abstract][Full Text] [Related]
9. A helicase-primase drug candidate with sufficient target tissue exposure affects latent neural herpes simplex virus infections.
Gege C; Bravo FJ; Uhlig N; Hagmaier T; Schmachtenberg R; Elis J; Burger-Kentischer A; Finkelmeier D; Hamprecht K; Grunwald T; Bernstein DI; Kleymann G
Sci Transl Med; 2021 Jun; 13(598):. PubMed ID: 34135112
[TBL] [Abstract][Full Text] [Related]
10. Antiviral Drugs Against Alphaherpesvirus.
Shiraki K
Adv Exp Med Biol; 2018; 1045():103-122. PubMed ID: 29896665
[TBL] [Abstract][Full Text] [Related]
11. Antiviral therapy of herpes simplex.
Snoeck R
Int J Antimicrob Agents; 2000 Oct; 16(2):157-9. PubMed ID: 11053800
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease.
Crute JJ; Grygon CA; Hargrave KD; Simoneau B; Faucher AM; Bolger G; Kibler P; Liuzzi M; Cordingley MG
Nat Med; 2002 Apr; 8(4):386-91. PubMed ID: 11927945
[TBL] [Abstract][Full Text] [Related]
13. Marine organisms as a therapeutic source against herpes simplex virus infection.
Vo TS; Ngo DH; Ta QV; Kim SK
Eur J Pharm Sci; 2011 Sep; 44(1-2):11-20. PubMed ID: 21782018
[TBL] [Abstract][Full Text] [Related]
14. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.
Sarisky RT; Bacon TH; Boon RJ; Duffy KE; Esser KM; Leary J; Locke LA; Nguyen TT; Quail MR; Saltzman R
Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088
[TBL] [Abstract][Full Text] [Related]
15. Famciclovir/penciclovir.
Sacks SL; Wilson B
Adv Exp Med Biol; 1999; 458():135-47. PubMed ID: 10549386
[No Abstract] [Full Text] [Related]
16. Antiviral drugs for varicella-zoster virus and herpes simplex virus infections.
Med Lett Drugs Ther; 2018 Sep; 60(1556):153-157. PubMed ID: 30383727
[No Abstract] [Full Text] [Related]
17. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
Wutzler P
Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
[TBL] [Abstract][Full Text] [Related]
18. [Antiherpetic chemotherapy].
Shiraki K; Kurokawa M
Nihon Rinsho; 2000 Apr; 58(4):939-43. PubMed ID: 10774220
[TBL] [Abstract][Full Text] [Related]
19. HSV antivirals - current and future treatment options.
Birkmann A; Zimmermann H
Curr Opin Virol; 2016 Jun; 18():9-13. PubMed ID: 26897058
[TBL] [Abstract][Full Text] [Related]
20. A new promising candidate to overcome drug resistant herpes simplex virus infections.
Zinser E; Krawczyk A; Mühl-Zürbes P; Aufderhorst U; Draßner C; Stich L; Zaja M; Strobl S; Steinkasserer A; Heilingloh CS
Antiviral Res; 2018 Jan; 149():202-210. PubMed ID: 29155164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
